Lauth Proudly Announces Michael J. Garvey as Candidate for the Leukemia & Lymphoma Society Man of the Year

Community Leaders Compete for the Title of Man & Woman of the Year

The Indiana Chapter of Leukemia & Lymphoma Society (LLS) will launch its 2014 Indianapolis Man & Woman of the Year competition on February 27, 2014, to raise money for cancer research and patient services.

Community leaders compete for the national title of Man & Woman of the Year, an honor surrounded with a great deal of fanfare, community support and local and national recognition. However, the most important reason candidates participate is for families like this year’s Boy & Girl of the Year, Zaki Siddiqui and Maeve Bigelow. Zaki and Maeve are childhood blood cancer survivors and are sources of inspiration for the candidates.

Lauth proudly announces that Michael J. Garvey, Chief Investment Officer and Partner, is participating as a 2014 candidate for “man of the year”.

The money raised by candidates over the ten-week period is used by LLS to fund research seeking cures and better therapies, and to provide information and support so that patients have the best possible outcomes throughout their cancer experience.

Every dollar raised counts as one “vote.” The male and female candidates with the most “votes” will be awarded the titles of 2014 Man & Woman of the Year at a Grand Finale Gala on May 10, 2014, at the JW Marriott Indianapolis, and then are entered into the competition for National Man & Woman of the Year.

To cast your vote for this year’s Man & Woman of the Year, to attend the Grand Finale Gala on May 10th, or to learn more about the campaign visit,

About Lauth

Lauth is a 36 year, management owned, full service real estate firm with expertise in development, construction, property management, and acquisitions. Additional Lauth information is available at

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society®, headquartered in White Plains, NY, is the world’s largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The LLS mission is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and to improve the quality of life patients and their families. Since its founding in 1949, LLS has invested more than $1 billion in research specifically targeting leukemia, lymphoma and myeloma. LLS has a local Patient Services Manager in 61 chapters throughout the United States and Canada. For additional information, please contact LLS at (800) 955-4572 or visit